Stocklytics Platform
Asset logo for symbol AXSM
Axsome Therapeutics
AXSM63
$98.23arrow_drop_down0.58%-$0.57
High Growth
Asset logo for symbol AXSM
AXSM63

$98.23

arrow_drop_down0.58%

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Axsome Therapeutics (AXSM) Stocklytics Forecast

Axsome Therapeutics Inc (AXSM) is a biopharmaceutical company focused on developing innovative therapies to improve the lives of patients with central nervous system (CNS) disorders. The company's pipeline includes several potential blockbuster drugs that are currently in various stages of clinical development. With a strong track record of success in bringing novel therapies to market, Axsome Therapeutics has garnered significant attention from investors and analysts alike. This has led to heightened interest in the company's stock and raised questions about its future prospects.
When it comes to predicting the future price of AXSM stock, there are several factors that need to be considered. One important factor is the performance of the company's existing products and the potential for future revenue growth. Axsome Therapeutics has a promising pipeline of CNS disorder therapies, including a potential breakthrough treatment for major depressive disorder. If these therapies prove successful in clinical trials and gain regulatory approval, they could significantly boost the company's revenue and drive up the stock price.
add Axsome Therapeutics  to watchlist

Keep an eye on Axsome Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Axsome Therapeutics (AXSM) stock?

Analysts have set a target price of $132.27 for Axsome Therapeutics (AXSM), based on forecasts from 30 analysts. The predicted price range extends from a high of $190 to a low of $103. This represents a potential increase of up to 93.41% and a decrease of 4.85% from the current price of $98.23. These forecasts are as of 2023 Dec 20.
help

What are the analyst ratings for Axsome Therapeutics (AXSM) stock?

The analyst ratings for Axsome Therapeutics (AXSM) are distributed as follows: 17 analysts recommend buying, 0 have a neutral stance, and 0 suggest selling. There is a split consensus, with equal support for two of the rating categories. These ratings indicate the general sentiment among the analysts covering Axsome Therapeutics .
help

What is the AI price prediction for Axsome Therapeutics (AXSM) stock?

At present, there is no AI or machine-learning-based price prediction available for Axsome Therapeutics (AXSM) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level